USPTO Examiner VIRK ADIL PARTAP S - Art Unit 3798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18746418NUCLEAR MAGNETIC RESONANCE SYSTEMS AND METHODS FOR NONINVASIVE AND IN-VIVO MEASUREMENTS USING A UNILATERAL MAGNETJune 2024June 2025Allow1200YesNo
18653383SYSTEMS AND METHODS FOR USING TRACKING IN IMAGE-GUIDED MEDICAL PROCEDUREMay 2024March 2025Allow1000YesNo
18533287REGISTRATION OF X-RAY AND ULTRASOUND IMAGESDecember 2023January 2025Allow1320NoNo
18377460SYSTEMS AND METHODS FOR PERFORMING TRANSCRANIAL ULTRASOUND THERAPEUTIC AND IMAGING PROCEDURESOctober 2023January 2025Allow1520NoNo
18464499Multi-Channel Real-Time Phase Modulation for EMI Reduction in an Ultrasound DeviceSeptember 2023April 2024Allow700YesNo
18279227A SYSTEM FOR TREATING VISUAL NEGLECTAugust 2023May 2025Abandon2110NoNo
18353386ULTRASONIC PROBE AND ULTRASONIC DIAGNOSTIC APPARATUSJuly 2023June 2025Allow2320NoNo
18219797ULTRASOUND PROBE, ULTRASOUND TRANSDUCER UNIT, AND ULTRASOUND ENDOSCOPEJuly 2023February 2025Allow1910YesNo
18214371METHODS OF USING PLANAR OR DEFOCUSED ACOUSTIC WAVES FOR NON-INVASIVE SONODYNAMIC THERAPYJune 2023January 2024Allow610NoNo
18311739OPTICAL COHERENCE TOMOGRAPHY GUIDED ROBOTIC OPHTHALMIC PROCEDURESMay 2023March 2024Allow1010NoNo
18248479SMARTPHONE-BASED MULTISPECTRAL DERMASCOPEApril 2023May 2025Allow2520YesNo
18026875SMART HOME DEVICE USING A SINGLE RADAR TRANSMISSION MODE FOR ACTIVITY RECOGNITION OF ACTIVE USERS AND VITAL SIGN MONITORING OF INACTIVE USERSMarch 2023February 2025Allow2311YesNo
18023895AUTOMATIC MALPOSITION DETECTION OF MEDICAL DEVICES IN MEDICAL IMAGESFebruary 2023February 2025Abandon2410NoNo
18151882ELECTRONIC DEVICE COMPRISING ULTRASONIC DEVICE AND PPG SIGNAL ACQUISITION METHOD THEREOFJanuary 2023January 2025Allow2420YesNo
18090652NUCLEAR MAGNETIC RESONANCE SYSTEMS AND METHODS FOR NONINVASIVE AND IN-VIVO MEASUREMENTS USING A UNILATERAL MAGNETDecember 2022March 2024Allow1420YesNo
17801218ASSISTING MEDICAL PROCEDURES WITH LUMINESCENCE IMAGES PROCESSED IN LIMITED INFORMATIVE REGIONS IDENTIFIED IN CORRESPONDING AUXILIARY IMAGESAugust 2022February 2025Allow3010YesNo
17814223SYSTEMS AND METHODS FOR FETUS MONITORINGJuly 2022August 2024Allow2510NoNo
17866975APPARATUS FOR CORRECTING POSTURE OF ULTRASOUND SCANNER FOR ARTIFICIAL INTELLIGENCE-TYPE ULTRASOUND SELF-DIAGNOSIS USING AUGMENTED REALITY GLASSES, AND REMOTE MEDICAL DIAGNOSIS METHOD USING SAMEJuly 2022July 2024Allow2410YesNo
17662946ULTRASOUND DIAGNOSTIC DEVICE AND STORAGE MEDIUMMay 2022March 2024Allow2320YesNo
17740163METHODS FOR MONITORING BLOOD PRESSURE OF A PERSON THAT UTILIZES VELOCITY AND PULSE WAVE SIGNAL INFORMATIONMay 2022January 2025Abandon3310NoNo
17740173SYSTEMS FOR MONITORING BLOOD PRESSURE OF A PERSON THAT UTILIZES VELOCITY AND PULSE WAVE SIGNAL INFORMATIONMay 2022January 2025Abandon3310NoNo
17735513ULTRASOUND ENDOSCOPEMay 2022January 2024Allow2100YesNo
17770679MONITORING SYSTEM WITH A CAMERA AND NON-METALLIC MIRROR FOR MAGNETIC RESONANCE EXAMINATION SYSTEMApril 2022July 2024Allow2710YesNo
17724561ADAPTION OF A MEDICAL COMPUTED TOMOGRAPHY IMAGING PROCESS TO AN INDIVIDUAL RESPIRATION BEHAVIOUR OF A PATIENTApril 2022February 2025Abandon3420YesNo
17770093MAGNETIC RESONANCE IMAGING SYSTEM WITH INTENTIONAL GRADIENT NOISEApril 2022August 2024Abandon2810NoNo
17679890METHOD OF DETERMINING SCAN PLANES IN THE ACQUISITION OF ULTRASOUND IMAGES AND ULTRASOUND SYSTEM FOR THE IMPLEMENTATION OF THE METHODFebruary 2022April 2025Allow3741YesNo
17634752ULTRASOUND-BASED DEVICE LOCALIZATIONFebruary 2022March 2025Allow3710NoNo
17666096SYSTEMS AND METHODS FOR USING TRACKING IN IMAGE-GUIDED MEDICAL PROCEDUREFebruary 2022January 2024Allow2421YesNo
17666171ULTRASONIC DIAGNOSTIC APPARATUS, ULTRASONIC DIAGNOSTIC SYSTEM, AND METHOD FOR USE WITH THE ULTRASONIC DIAGNOSTIC APPARATUSFebruary 2022January 2025Allow3510YesNo
17597081DISPLAY DEVICE, DISPLAY METHOD, AND ULTRASONIC DIAGNOSTIC SYSTEMDecember 2021June 2024Allow3010YesNo
17597042METHOD FOR PLANNING TISSUE ABLATION BASED ON DEEP LEARNINGDecember 2021April 2024Allow2810YesNo
17620828ULTRASOUND MARKER, ULTRASOUND MARKER SYSTEM AND METHOD OF OPERATING AN ULTRASOUND MARKER SYSTEMDecember 2021May 2024Abandon2910NoNo
17618014ULTRASONIC DOPPLER BLOOD FLOW IMAGING METHOD AND SYSTEMDecember 2021May 2024Abandon3010YesNo
17618087VIBRATION-GENERATING DEVICEDecember 2021May 2024Allow3010YesNo
17546358HOT DEVICE INDICATION OF VIDEO DISPLAYDecember 2021February 2025Allow3820YesNo
17533572WETTING FOR USE IN PROLONGED IMAGING PROCEDURESNovember 2021March 2024Allow2721YesNo
17613654SYSTEMS AND METHODS FOR REDUCING THERMAL SKULL-INDUCED ABERRATIONS DURING TRANSCRANIAL ULTRASOUND THERAPEUTIC PROCEDURESNovember 2021January 2025Allow3831YesNo
17611650SYSTEM, DEVICE AND METHOD FOR ASSISTANCE WITH CERVICAL ULTRASOUND EXAMINATIONNovember 2021March 2025Abandon4030YesNo
17520974METHOD AND APPARATUS FOR TAKING INTO ACCOUNT SUSCEPTIBILITY DEVIATIONS IN MR-BASED THERAPY PLANNINGNovember 2021April 2025Abandon4120NoNo
17608528PATIENT MARKERNovember 2021June 2024Abandon3110NoNo
17608319SLEEP TRACKING AND VITAL SIGN MONITORING USING LOW POWER RADIO WAVESNovember 2021June 2024Allow3110YesNo
17514326ULTRASOUND DIAGNOSTIC APPARATUS, METHOD OF CONTROLLING ULTRASOUND DIAGNOSTIC APPARATUS, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM STORING THEREIN COMPUTER-READABLE PROGRAM FOR CONTROLLING ULTRASOUND DIAGNOSTIC APPARATUSOctober 2021March 2024Allow2930YesNo
17450020Methods for Controlling Cooperative Surgical InstrumentsOctober 2021April 2025Allow4231YesNo
17439383DEVICE AND METHOD FOR ANALYZING OPTOACOUSTIC DATA, OPTOACOUSTIC SYSTEM AND COMPUTER PROGRAMSeptember 2021May 2025Abandon4421YesNo
17467261IMAGING DEVICE AND IMAGING METHODSeptember 2021October 2024Abandon3730YesNo
17399586MIXED REALITY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOPGRAPHY (ERCP) PROCEDUREAugust 2021March 2024Allow3120YesNo
17419083ULTRASOUND SYSTEM AND METHOD FOR SHEAR WAVE CHARACTERIZATION OF ANISOTROPIC TISSUEJune 2021January 2025Abandon4330NoNo
17303082SYSTEMS FOR TREATING PEYRONIES DISEASEMay 2021February 2025Allow4520YesNo
17315543COMPUTER-IMPLEMENTED METHOD FOR CLASSIFYING A BODY TYPEMay 2021January 2025Allow4540YesNo
17161510MULTI FUNCTIONAL PROBE CAPABLE OF SHIELDING ELECTROMAGNETIC WAVEJanuary 2021June 2025Allow5340YesYes
17158315LED INDUCED FLUORESCENCE DETECTION SYSTEM OF EPITHELIAL TISSUEJanuary 2021June 2023Abandon2901NoNo
17157524ULTRASOUND DIAGNOSTIC APPARATUS AND METHOD OF CONTROLLING ULTRASOUND DIAGNOSTIC APPARATUSJanuary 2021March 2025Abandon5060YesNo
17111942SYSTEMS AND METHODS FOR MULTIMODAL NEURAL SENSINGDecember 2020March 2025Allow5130YesNo
17110088MEDICAL PROCESSING APPARATUS, ULTRASOUND DIAGNOSTIC APPARATUS, AND MEDICAL PROCESSING METHODDecember 2020February 2024Abandon3911NoNo
17053945ULTRASONIC IMAGING BY SPARSE SAMPLING AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSNovember 2020March 2024Allow4030YesNo
17029914PATIENT BEARING SYSTEM, A ROBOTIC SYSTEMSeptember 2020April 2024Abandon4350YesNo
17016623METHOD AND SYSTEM FOR ADAPTING USER INTERFACE ELEMENTS BASED ON REAL-TIME ANATOMICAL STRUCTURE RECOGNITION IN ACQUIRED ULTRASOUND IMAGE VIEWSSeptember 2020May 2025Abandon5640YesNo
16985442METHOD AND SYSTEM FOR SHEAR WAVE ELASTOGRAPHY AND MEDIUM STORING CORRESPONDING PROGRAMAugust 2020April 2024Abandon4550NoNo
16939218METHOD AND MAGNETIC RESONANCE APPARATUS FOR SYNCHRONOUS IMAGING AND RADIATION THERAPYJuly 2020September 2023Allow3730YesNo
16769469SYSTEMS, DEVICE AND METHODS PROVIDING A COMBINED ANALYSIS OF IMAGING AND LASER MEASUREMENTJune 2020March 2025Abandon5740YesNo
16766726SPATIAL REGISTRATION METHOD FOR IMAGING DEVICESMay 2020January 2025Abandon5531YesNo
16798665ANALYSIS APPARATUS AND ULTRASOUND DIAGNOSIS APPARATUSFebruary 2020January 2025Allow5941YesNo
16790941ULTRASOUND DIAGNOSTIC SYSTEM AND METHOD OF OPERATING ULTRASOUND DIAGNOSTIC SYSTEMFebruary 2020October 2024Abandon5660YesNo
16697363TOPOGRAM-BASED FAT QUANTIFICATION FOR A COMPUTED TOMOGRAPHY EXAMINATIONNovember 2019November 2023Allow4730YesNo
16468029Method of, and apparatus for, non-invasive medical imaging using waveform inversionJune 2019August 2024Abandon6040YesNo
16404957PATIENT COUCH WITH APPARATUS FOR REVERSIBLY RECEIVING A TRANSFER BOARDMay 2019May 2024Abandon6040YesNo
16183886ULTRASOUND SYSTEM WITH HIGH FREQUENCY DETAILNovember 2018February 2024Abandon6040YesNo
16088125FLEXIBLE SUPPORT MEMBER FOR INTRAVASCULAR IMAGING DEVICE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSSeptember 2018July 2024Abandon6091YesNo
16088288TWO DIMENSIONAL ULTRASONIC ARRAY TRANSDUCER WITH ONE DIMENSIONAL PATCHESSeptember 2018October 2023Allow6020YesYes
16069082AUTOMATIC PROBE STEERING TO CLINICAL VIEWS USING ANNOTATIONS IN A FUSED IMAGE GUIDANCE SYSTEMJuly 2018December 2024Abandon6080NoNo
15957103Method for Diagnosing and Treating HemorrhoidsApril 2018September 2024Allow6050YesYes
15759319MEDICAL IMAGE PROCESSING APPARATUS, TREATMENT SYSTEM, AND MEDICAL IMAGE PROCESSING PROGRAMMarch 2018April 2024Abandon6060NoNo
15874523ULTRASOUND DIAGNOSTIC APPARATUSJanuary 2018January 2025Abandon60120YesNo
15681536MEDICAL IMAGE DIAGNOSTIC APPARATUSAugust 2017May 2024Abandon6051YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner VIRK, ADIL PARTAP S.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
20.2%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
3
(100.0%)
Filing Benefit Percentile
9.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner VIRK, ADIL PARTAP S - Prosecution Strategy Guide

Executive Summary

Examiner VIRK, ADIL PARTAP S works in Art Unit 3798 and has examined 72 patent applications in our dataset. With an allowance rate of 56.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner VIRK, ADIL PARTAP S's allowance rate of 56.9% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by VIRK, ADIL PARTAP S receive 2.65 office actions before reaching final disposition. This places the examiner in the 89% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by VIRK, ADIL PARTAP S is 37 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +33.3% benefit to allowance rate for applications examined by VIRK, ADIL PARTAP S. This interview benefit is in the 84% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.4% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.6% of cases where such amendments are filed. This entry rate is in the 14% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 32% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 62% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.